Atalanta Therapeutics
Atalanta Therapeutics » Home
Boston, United States · $207.0M raised
- Headquarters
- Boston
- Employees
- 51–200
- Business Model
- B2B
- Website
- atalantatx.com
- Total Funding
- $207.0M
- Last Round
- $97.0M Series BJan 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biotech developing branched siRNA therapeutics for neurological diseases using Nobel-winning RNAi discoveries.
Summary
Atalanta Therapeutics is a Biotech company based in Boston, United States. It has raised $207.0M in total across 2 rounds, most recently a $97.0M Series B round in Jan 2025. Investors include EQT AB and F-Prime Capital.
Tech & App Stack
8 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2025
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/atalanta-therapeutics"><img src="https://indexed.vc/api/badge/company/atalanta-therapeutics" alt="Atalanta Therapeutics on Indexed.vc" width="260" height="76" /></a>